Health Care/Hospital

Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights

HONG KONG, April 30, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced today that the Company will acquire 100% ...

2022-04-30 04:16 9177

Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

LONDON, April 30, 2022 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire announcement issued today indicating that Opiant Pharmaceuticals and Hikma have entered into a commercialisation an...

2022-04-30 02:08 2611

Antengene Announces Latest Clinical Trial Data of ATG-008 (onatasertib) to be presented in the upcoming 2022 American Society of Clinical Oncology Annual Meeting

SHANGHAI and HONG KONG, April 29, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onc...

2022-04-29 22:30 2763

Biocytogen Enters into Antibody Agreement with Merck

BEIJING, April 29, 2022 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and option agreement with Merck to grant them a sole license to evaluate Biocytogen's proprietary antibodies against at least three distinct targets...

2022-04-29 20:00 2514

The unrecognised return on investment of creating children from assisted reproduction

SINGAPORE, April 29, 2022 /PRNewswire/ -- A serious decline in world population numbers and its major economic and social ramifications in coming decades can be addressed by recognition of the life-long benefits generated by children born from assisted reproduction. This was the thrust of a ke...

2022-04-29 17:23 1878

New IFPA report reveals link between psoriatic disease and mental health

STOCKHOLM, April 29, 2022 /PRNewswire/ -- Psoriatic disease is an inflammatory illness that affects the skin and joints. Itchy, flaky patches of skin are perhaps the most common symptom. But psoriatic disease goes far deeper. For many, one of the most difficult challenges in living with psoriatic...

2022-04-29 14:00 2260

Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Greater sense of patient empowerment with telemedicine trends in IVF services

SINGAPORE, April 29, 2022 /PRNewswire/ -- Telemedicine that became a vital engagement tool between health professionals and patients during the COVID-19 pandemic is emerging as a welcome new treatment of choice among fertility clinics and couples striving for parenthood. Patients seeking assiste...

2022-04-29 10:50 4173

Transcenta to Present Clinical Trial Data of TST001 and MSB0254 at 2022 ASCO Annual Meeting

SUZHOU, China, April 29, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the abstracts o...

2022-04-29 10:33 2641

Dr Ivan Puah Explains Major Differences Between Buccal Fat Removal And Cheek Liposuction Results

Depending on your beauty goal, it is crucial to understand better the true result difference between buccal fat pad removal and cheek liposuction before committing to the surgery. SINGAPORE, April 29, 2022 /PRNewswire/ -- Buccal fat removal, also known as buccal lipectomy, is a facial cosme...

2022-04-29 08:29 2208

Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama

FREDERICK, Md., April 29, 2022 /PRNewswire/ -- Healion Bio, a closely held biotechnology company, today announced a collaborative agreement to research a combination antiviral against SARS-CoV-2 and other deadly pathogens. The combination will include one of Healion Bio's protease inhibitors and ...

2022-04-29 01:00 2118

Varian partners with Icon Group to advance patient-centric solutions

Bringing clinical insights into early product development PALO ALTO, Calif. and SYDNEY, April 28, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company (Varian), today announced a five-year research and professional services agreement with Icon Group (Icon). Through this agreement, Icon wi...

2022-04-28 23:00 1996

IMG Travel Outlook Survey Reports International Travel in 2022 to Surpass Pre-Pandemic Levels

* Survey results reveal travel trends for 2022 that include willingness to travel internationally, comfort level of traveling internationally compared to 2021, and insurance benefits travelers care about most INDIANAPOLIS, April 28, 2022 /PRNewswire/ -- International Medical Group® (IMG®), an a...

2022-04-28 21:20 1528

United Imaging Healthcare bags Healthcare Asia Medtech Award

SHANGHAI, April 28, 2022 /PRNewswire/ -- United Imaging Healthcare was recognised with the Imaging Product Innovation of the Year Award at the Healthcare Asia Medtech Awards with its three groundbreaking products: the Total-body PET/CT uEXPLORER, the 3.0T uMR Omega, and uRT-linac 506c. United Im...

2022-04-28 18:28 2928

Transcenta Announces First Patient Dosed in China Study of Anti-sclerostin Monoclonal Antibody TST002 for the Treatment of Osteoporosis

SUZHOU, China, April 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the successful dosin...

2022-04-28 17:06 1864

Manulife Hong Kong Partners with Christian Family Service Centre to Support Health Recovery of Elderly and Build Resilience

End-to-end healthcare initiative showcases Manulife's commitment to helping vulnerable seniors to safely access medical services from home HONG KONG, April 28, 2022 /PRNewswire/ -- Manulife Hong Kong is supporting elderly singles and couples with limited family support, or those with mobility pr...

2022-04-28 16:45 2117

The Danish National Genome Center Partners with Lifebit to Deliver Nationwide Personalised Medicine

The Danish National Genome Center has awarded Lifebit a four-year contract to implement Lifebit's Federated Trusted Research Environment software, Lifebit CloudOS, withinDenmark's national supercomputing center. LONDON, April 28, 2022 /PRNewswire/ -- Lifebit, whose leading technology enable...

2022-04-28 14:00 2333

Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress

Infertile women continue to be marginalised and excluded from treatment in developing countries SINGAPORE, April 28, 2022 /PRNewswire/ -- Women living with infertility in many developing countries are victims of a systemic process of cultural and institutional exclusion from assisted reproductiv...

2022-04-28 13:43 1605

HealthBeats Raises US$3m Seed Funding Led By Heritas Capital And SEEDS Capital To Expand Remote Vitals Monitoring In Australia And Singapore

SINGAPORE and SYDNEY and NEW YORK, April 28, 2022 /PRNewswire/ -- HealthBeatsTM , aSingapore-based healthtech start-up with end-to-end remote vitals monitoring solution, today announced the close of aUS$3m Seed round led by healthcare investor Heritas Capital together with SEEDS Capital, the inves...

2022-04-28 08:15 2140

CStone to present the latest clinical results of anti-PD-L1 antibody sugemalimab and anti-PD-1 antibody nofazinlimab at ASCO 2022

* Results from GEMSTONE-201 study of sugemalimab, the first successful registrational clinical study to date evaluating an anti-PD-(L)1 antibody targeting patients with relapsed or refractory extranodal natural killer/T-cell lymphoma, will be presented in an oral abstract session * The protoc...

2022-04-28 08:00 2135

Zimmer Biomet's mymobility is recognized as "The Care Management Initiative of the Year" by the 2022 Healthcare Asia Medtech Awards

SINGAPORE, April 28, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that the company's mymobility® digital care management platform won "The Care Management Initiative of the Year" award at this year's Healthcare Asia Med...

2022-04-28 08:00 2770
1 ... 204205206207208209210 ... 553